JP2025503400A5 - - Google Patents
Info
- Publication number
- JP2025503400A5 JP2025503400A5 JP2024534202A JP2024534202A JP2025503400A5 JP 2025503400 A5 JP2025503400 A5 JP 2025503400A5 JP 2024534202 A JP2024534202 A JP 2024534202A JP 2024534202 A JP2024534202 A JP 2024534202A JP 2025503400 A5 JP2025503400 A5 JP 2025503400A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163288284P | 2021-12-10 | 2021-12-10 | |
| US63/288,284 | 2021-12-10 | ||
| PCT/US2022/081297 WO2023108138A1 (en) | 2021-12-10 | 2022-12-09 | Fully canine anti-canine pd-1 antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503400A JP2025503400A (ja) | 2025-02-04 |
| JP2025503400A5 true JP2025503400A5 (cg-RX-API-DMAC7.html) | 2025-12-16 |
Family
ID=86731339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534202A Pending JP2025503400A (ja) | 2021-12-10 | 2022-12-09 | 完全イヌ抗イヌpd-1抗体およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250051447A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4444754A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025503400A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240139600A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118922441A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3240188A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023108138A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025106547A1 (en) * | 2023-11-14 | 2025-05-22 | The Trustees Of Dartmouth College | Anti-canine pd-1 antibodies, compositions containing, and therapeutic or diagnostic use thereof |
| WO2025113570A1 (en) * | 2023-11-29 | 2025-06-05 | Vetigenics, Inc. | Fully canine antibodies and uses thereof |
| CN117343185B (zh) * | 2023-12-06 | 2024-03-01 | 北京伟杰信生物科技有限公司 | 一种抗犬pd-1抗体及其用途 |
| CN121824759A (zh) * | 2025-11-26 | 2026-04-10 | 广东海大集团股份有限公司 | 一种靶向犬pd-1蛋白的单克隆抗体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009126730A2 (en) * | 2008-04-09 | 2009-10-15 | The Trustees Of The University Of Pennsylvania | Canine single chain fragment variable antibody libraries and uses thereof |
| AU2014368453B2 (en) * | 2013-12-20 | 2020-04-16 | Intervet International B.V. | Caninized murine anti-canine PD-1 antibodies |
| EP3448874A4 (en) * | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| JP7469305B2 (ja) * | 2018-11-19 | 2024-04-16 | バイオサイトジェン ファーマシューティカルズ (ベイジン) カンパニー リミテッド | 抗pd-1抗体およびその使用 |
-
2022
- 2022-12-09 EP EP22905423.4A patent/EP4444754A4/en active Pending
- 2022-12-09 CN CN202280091132.2A patent/CN118922441A/zh active Pending
- 2022-12-09 KR KR1020247022132A patent/KR20240139600A/ko active Pending
- 2022-12-09 WO PCT/US2022/081297 patent/WO2023108138A1/en not_active Ceased
- 2022-12-09 US US18/718,387 patent/US20250051447A1/en active Pending
- 2022-12-09 CA CA3240188A patent/CA3240188A1/en active Pending
- 2022-12-09 JP JP2024534202A patent/JP2025503400A/ja active Pending